SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
TAMPA, Fla., March 15, 2018 -- United Consortium Ltd. (OTC PINK:UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Blockchain, Digital Media and the Emerging Cannabis Space, today announced that its wholly owned subsidiary Block Chain, Inc. has launched the beta version of its new PHR Blockchain project.
UCL Chairman and Chief Executive Officer Scott Gallagher stated, “Today marks an important step forward in our journey to turn our blockchain based idea, into a viable business opportunity with the potential to disrupt how we access and utilize our health records.” Gallagher continued, “We expect the beta period to last several months as we test our methods, collect data and tackle some of the hurdles we’ve identified. Our plan is to have the public version 1.0 set for release this summer. Version 1.0 will have a valuable set of user tools that will transfer complete ownership of personal health records back where it belongs, to the patient.”
About United Consortium Ltd. (UCL)
UCL is an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Blockchain, Digital Media and the Emerging Cannabis Space. The Company is headquartered in Tampa, Florida. UCL is a current pink sheet Company. The most current information about the Company can be found on OTCMarkets.com or by visiting the Company's website at www.UCLVentures.com.
Forward-Looking Statements
This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL's) future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words "plans," "anticipates," "expects" and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in United Consortium Ltd.’s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.
Contact Information
For additional information contact:
Scott Gallagher
727-417-7807
